UK's IQ-AI rises after FDA grants orphan status to unit's tumour drug

Imaging Biometrics

09/10/2023 09:31

** Shares of medical services and software co IQ-AI  IQAI.L 
up 5.2% at 4.17 pence
    ** Co's subsidiary Imaging Biometrics gets U.S. Food and
Drug Administration's orphan drug status for gallium maltolate
(GaM), used to treat atypical teratoid rhabdoid tumour - a type
of rare brain tumour
    ** This is the second orphan designation granted to GaM by
FDA this year
    ** Stock up ~107.6% YTD, as of last close


 (Reporting by Meenakshi Maidas in Bengaluru)
 ((meenakshi.maidas@thomsonreuters.com;))